ImmunityBio, Inc.IBRXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank58
3Y CAGR-5.5%
5Y CAGR+20.4%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-5.5%/yr
vs +57.9%/yr prior
5Y CAGR
+20.4%/yr
Recent deceleration
Acceleration
-63.4pp
Decelerating
Percentile
P58
Within normal range
vs 5Y Ago
2.5x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $88.33M | -38.4% |
| 2024 | $143.43M | -46.0% |
| 2023 | $265.45M | +153.7% |
| 2022 | $104.64M | -42.2% |
| 2021 | $181.10M | +418.7% |
| 2020 | $34.91M | +125.1% |
| 2019 | $15.51M | -7.8% |
| 2018 | $16.82M | -29.5% |
| 2017 | $23.87M | +195.3% |
| 2016 | $8.08M | - |